COM:BIOFRONTERA-US
Biofrontera Inc.
- Stock
Last Close
0.78
21/11 21:00
Market Cap
4.99M
Beta: -
Volume Today
63.64K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 8.79M - | 5.77M 34.27% | 5.81M 0.67% | 9.04M 55.48% | ||
average payables | 498.50K - | 417K 16.35% | 968K 132.13% | 2.29M 136.88% | ||
average receivables | 4.04M - | 7.86M 94.67% | 9.92M 26.19% | 6.28M 36.64% | ||
book value per share | -52.03 - | 10.05 119.31% | 25.74 156.20% | 1.13 95.61% | ||
capex per share | -0.93 - | -0.02 - | -0.00 92.80% | |||
capex to depreciation | -0.81 - | -0.02 - | -0.03 59.17% | -0.01 76.13% | ||
capex to operating cash flow | 0.01 - | 0.00 - | 0.00 469.72% | 0.00 91.44% | ||
capex to revenue | -0.02 - | -0.00 - | -0.00 190.35% | -0.00 88.90% | ||
cash per share | 12.59 - | 13.93 10.65% | 55.73 300.06% | 1.31 97.64% | ||
days of inventory on hand | 308.28 - | 285.49 7.40% | 127.70 55.27% | 172.30 34.92% | 237.14 37.64% | |
days payables outstanding | 24.15 - | 7.09 70.66% | 18.85 166.01% | 30.72 62.98% | 71.92 134.11% | |
days sales outstanding | 66.72 - | 63.69 4.55% | 188.27 195.61% | 94.27 49.93% | 55.41 41.23% | |
debt to assets | 1.33 - | 0.13 - | 0.03 78.97% | 0.19 630.71% | ||
debt to equity | -1.27 - | 0.59 - | 0.06 90.45% | 1.13 1,898.37% | ||
dividend yield | ||||||
earnings yield | -0.21 - | -0.21 0.05% | -0.57 165.10% | -0.00 99.71% | ||
enterprise value | 82.05M - | 43.08M 47.50% | 41.69M 3.21% | 371.84M 791.86% | 4.06M 98.91% | |
enterprise value over ebitda | -9.37 - | -6.64 29.20% | -1.66 75.03% | -17.56 959.74% | -0.18 98.98% | |
ev to operating cash flow | -2.18 - | -3.48 59.91% | -1.56 55.19% | -22.95 1,370.83% | -0.16 99.29% | |
ev to sales | 3.13 - | 2.29 27.08% | 1.73 24.30% | 12.97 649.59% | 0.12 99.08% | |
free cash flow per share | -65.89 - | -21.33 67.63% | -60.68 184.56% | -0.77 98.73% | ||
free cash flow yield | -0.75 - | -0.24 67.63% | -0.40 66.87% | -0.04 89.62% | ||
graham net net | -73.79 - | -7.27 90.15% | -13.13 80.59% | 0.47 103.56% | ||
graham number | 148.89 - | 65.44 56.05% | 222.71 240.32% | 0.88 99.61% | ||
income quality | 3.43 - | 1.13 67.19% | 0.71 37.08% | 25.31 3,473.09% | 1.24 95.11% | |
intangibles to total assets | 0.15 - | 0.16 7.50% | 0.06 59.56% | 0.06 8.08% | 0.09 57.96% | |
interest coverage | -6.91 - | -2.88 58.38% | -75.15 2,512.24% | -114.77 52.73% | 48.46 142.22% | |
interest debt per share | 69.58 - | 4.99 92.82% | 15.98 219.94% | 0.07 99.54% | ||
inventory turnover | 1.18 - | 1.28 7.99% | 2.86 123.56% | 2.12 25.88% | 1.54 27.35% | |
invested capital | -1.27 - | 0.59 - | 0.06 90.45% | 1.13 1,898.37% | ||
market cap | 51.16M - | 51.16M 0% | 66.24M 29.48% | 387.70M 485.32% | ||
net current asset value | -35.46M - | 1.27M 103.57% | 4.54M 258.61% | 16.14M 255.40% | -64K 100.40% | |
net debt to ebitda | -3.53 - | 1.24 135.27% | 0.98 21.64% | 0.75 23.21% | -0.18 123.88% | |
net income per share | -18.93 - | -18.94 0.05% | -85.63 352.05% | -0.03 99.96% | ||
operating cash flow per share | -64.96 - | -21.33 67.17% | -60.66 184.44% | -0.77 98.74% | ||
payables turnover | 15.11 - | 51.51 240.84% | 19.36 62.41% | 11.88 38.64% | 5.08 57.29% | |
receivables turnover | 5.47 - | 5.73 4.76% | 1.94 66.17% | 3.87 99.71% | 6.59 70.15% | |
research and ddevelopement to revenue | 0.00 - | |||||
return on tangible assets | -0.45 - | -0.54 20.76% | -0.76 39.79% | -0.01 98.23% | -0.80 5,848.58% | |
revenue per share | 45.14 - | 32.50 28.01% | 54.72 68.38% | 1.36 97.52% | ||
roe | 0.36 - | -1.89 618.06% | -3.33 76.44% | -0.03 99.19% | -4.20 15,570.91% | |
roic | -1.87 - | -1.44 22.92% | -1.44 0.18% | -0.89 38.25% | -1.94 119.00% | |
sales general and administrative to revenue | 1.10 - | 0.96 12.30% | 1.54 60.63% | 1.25 18.98% | ||
shareholders equity per share | -52.03 - | 10.05 119.31% | 25.74 156.20% | 1.13 95.61% | ||
stock based compensation to revenue | 0.01 - | 0.06 1,106.65% | 0.03 52.42% | |||
tangible asset value | -34.47M - | 1.96M 105.68% | 7.89M 302.65% | 20.85M 164.29% | 2.16M 89.62% | |
tangible book value per share | -59.42 - | 3.38 105.68% | 17.91 430.28% | 0.99 94.49% | ||
working capital | 11.73M - | 15.16M 29.25% | 32.59M 115.00% | 22.25M 31.73% | 4.99M 77.58% |
All numbers in (except ratios and percentages)